menu
    • menu

    Company profile for Vyripharm Biopharmaceuticals

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vyripharm is a biopharmaceutical firm focused in neurological disorders and cancer. Our mission is the integration of traditional medicine with alternative medicine. The company has patents in sectors such as Regulatory Testing, Pharmaceutical and Diagnostic Drugs, Bioinformatics, Medical Informatics, Monitoring Technology, and Drug Delivery Systems. The company holds exclusive licenses, issued patents, patents pending and tra...
    Vyripharm is a biopharmaceutical firm focused in neurological disorders and cancer. Our mission is the integration of traditional medicine with alternative medicine. The company has patents in sectors such as Regulatory Testing, Pharmaceutical and Diagnostic Drugs, Bioinformatics, Medical Informatics, Monitoring Technology, and Drug Delivery Systems. The company holds exclusive licenses, issued patents, patents pending and trademarks.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vyripharm BiopharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Vyripharm Biopharmaceuticals TMCX+, 2450 Holcombe Blvd Houston, TX 77021
    Telephone
    Telephone
    (713) 357-1045
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://vyripharmbio.com/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vyripharm & ABB collaborate on the development of Automation and Robotics
    Vyripharm & ABB collaborate on the development of Automation and Robotics

    17 Oct 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221017005591/en

    BUSINESSWIRE
    17 Oct 2022
    Share Share
    NYMU in Taiwan collaborates with US firm
    NYMU in Taiwan collaborates with US firm

    21 Aug 2020

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/26/16562/nymu-in-taiwan-collaborates-with-us-firm.html

    BIOSPECTRUMASIA
    21 Aug 2020
    Share Share
    NYMU in Taiwan collaborates with US firm
    NYMU in Taiwan collaborates with US firm

    20 Aug 2020

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/26/16562/nymu-in-taiwan-collaborates-with-us-firm.html

    BIOSPECTRUMASIA
    20 Aug 2020
    Share Share
    Vyripharm Biopharmaceuticals and Regis Technologies, Inc. Have Signed Off
    Vyripharm Biopharmaceuticals and Regis Technologies, Inc. Have Signed Off

    15 Jun 2020

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20200615005687/en

    BUSINESSWIRE
    15 Jun 2020
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search